| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net earnings | 278,000 | 164,900 | 261,500 | 238,300 |
| Earnings from discontinued operations, net of tax | NaN | 0 | NaN | NaN |
| Depreciation and amortization | 173,300 | 173,000 | 171,000 | 170,300 |
| Stock compensation | 31,700 | 29,700 | 29,200 | 34,100 |
| Operating lease right-of-use asset expense | 48,000 | 59,000 | 49,700 | 50,800 |
| Asset impairment charges | NaN | 4,300 | NaN | NaN |
| Goodwill and other asset impairments | NaN | NaN | 700 | 0 |
| Non-cash portion of restructuring and other charges | NaN | 101,300 | NaN | NaN |
| Deferred income taxes | -2,000 | -174,000 | 88,600 | -12,200 |
| Other, net | 11,400 | 19,000 | 5,600 | 38,000 |
| Increase in accounts receivable | 187,900 | -4,900 | -9,500 | -30,900 |
| (increase) decrease in unbilled services | 6,200 | 600 | 900 | -900 |
| Decrease in supplies inventory | -35,400 | 12,300 | 14,400 | 11,900 |
| Decrease in prepaid expenses and other | -4,000 | 41,000 | 42,000 | -12,800 |
| Decrease in accounts payable | -138,700 | 151,600 | -123,800 | 67,000 |
| Decrease in unearned revenue | -32,100 | 47,200 | -3,900 | 200 |
| Decrease in accrued expenses and other | -27,400 | -107,300 | -43,600 | -4,700 |
| Net cash provided by continuing operating activities | NaN | 1,640,500 | NaN | NaN |
| Net cash provided by discontinued operating activities | NaN | 0 | NaN | NaN |
| Net cash provided by operating activities | 191,500 | 614,200 | 387,200 | 620,600 |
| Capital expenditures | 121,000 | 123,900 | 106,700 | 77,900 |
| Proceeds from sale of assets | 7,800 | 4,500 | 1,100 | 1,900 |
| Proceeds from sale of business | NaN | NaN | 0 | 0 |
| Proceeds from sale or distribution of equity affiliates or other investments | NaN | 0 | 0 | 6,900 |
| Proceeds from sale of business | NaN | 0 | NaN | NaN |
| Purchase of equity affiliates or other investments | 6,700 | 12,500 | 7,900 | 172,000 |
| Acquisition of businesses, net of cash acquired | 202,200 | 258,000 | 260,500 | 10,000 |
| Net cash used for continuing investing activities | NaN | -1,194,000 | NaN | NaN |
| Net cash used for discontinued investing activities | NaN | 0 | NaN | NaN |
| Net cash used for investing activities | -322,100 | -389,900 | -374,000 | -94,100 |
| Proceeds from senior note offerings | NaN | 0 | 0 | NaN |
| Proceeds from term loan | 750,000 | NaN | NaN | NaN |
| Payments on senior notes | 0 | 0 | 0 | 0 |
| Proceeds from revolving credit facilities | 0 | 0 | 0 | 0 |
| Payments on revolving credit facilities | 0 | 0 | 0 | 0 |
| Proceeds from accounts receivable securitization | 0 | 0 | 0 | 0 |
| Net share settlement tax payments from issuance of stock to employees | 39,800 | 1,300 | 1,600 | 3,500 |
| Net proceeds from issuance of stock to employees | 32,900 | 0 | 28,600 | 0 |
| Dividends paid | 61,200 | 59,300 | 59,900 | 59,900 |
| Purchase of common stock | 98,000 | 225,000 | 25,000 | 200,000 |
| Other, net | -3,400 | -4,800 | -1,600 | -4,000 |
| Net cash (used for) provided by continuing financing activities | NaN | -1,457,000 | NaN | NaN |
| Net cash provided by discontinued financing activities | NaN | 0 | NaN | NaN |
| Net cash provided by (used for) financing activities | 580,500 | -290,400 | -59,500 | -267,400 |
| Effect of exchange rate changes on cash and cash equivalents | NaN | 24,100 | NaN | NaN |
| Effect of exchange rate on changes in cash and cash equivalents | -17,000 | NaN | -2,900 | 18,800 |
| Net increase (decrease) in cash and cash equivalents | 448,800 | -65,800 | -49,200 | 277,900 |
| Cash and cash equivalents at beginning of period | NaN | NaN | 369,400 | 369,400 |
| Cash and cash equivalents at beginning of period | 532,300 | 369,400 | 369,400 | 369,400 |
| Cash and cash equivalents | 981,100 | 532,300 | NaN | NaN |
LABCORP HOLDINGS INC. (LH)
LABCORP HOLDINGS INC. (LH)